These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 642864)
21. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population. Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534 [TBL] [Abstract][Full Text] [Related]
22. [On the treatment of carcinoma of the thyroid (author's transl)]. Biersack HJ; Vogt M; Helpap B; Janson R; Rau W; Winkler C Dtsch Med Wochenschr; 1981 Mar; 106(13):390-5. PubMed ID: 7215162 [TBL] [Abstract][Full Text] [Related]
24. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Saad MF; Ordonez NG; Rashid RK; Guido JJ; Hill CS; Hickey RC; Samaan NA Medicine (Baltimore); 1984 Nov; 63(6):319-42. PubMed ID: 6503683 [TBL] [Abstract][Full Text] [Related]
26. [Current state of the treatment of thyroid cancer]. Paches AI; Liubaev VL; Shental' VV; Pustynskiĭ IN; Abdullin NA Vopr Onkol; 1998; 44(5):562-6. PubMed ID: 9884715 [TBL] [Abstract][Full Text] [Related]
27. [Therapeutic approach to differentiated carcinoma of the thyroid gland]. Busnardo B Minerva Endocrinol; 1987; 12(1):69-73. PubMed ID: 3587203 [No Abstract] [Full Text] [Related]
28. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224 [TBL] [Abstract][Full Text] [Related]
29. Contemporary management of papillary carcinoma of the thyroid gland. Rosenbaum MA; McHenry CR Expert Rev Anticancer Ther; 2009 Mar; 9(3):317-29. PubMed ID: 19275510 [TBL] [Abstract][Full Text] [Related]
30. [Poorly differentiated thyroid follicular carcinoma - a clinical analysis of 30 cases]. Liu WS; Qi YF; Tang PZ Ai Zheng; 2004 Sep; 23(9):1081-4. PubMed ID: 15363207 [TBL] [Abstract][Full Text] [Related]
31. [One stage thyroidectomy and bilateral neck dissection for well-differentiated thyroid carcinoma]. Pan YF; Zhang XH; Ye GH; Lin BR; Chen XM; Jia XJ; Zhou SM; Wang OC Zhonghua Zhong Liu Za Zhi; 2006 May; 28(5):389-92. PubMed ID: 17045009 [TBL] [Abstract][Full Text] [Related]
32. High recurrent rate of multicentric papillary thyroid carcinoma. Lin JD; Chao TC; Hsueh C; Kuo SF Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244 [TBL] [Abstract][Full Text] [Related]
33. Radioactive iodine treatment in medullary thyroid carcinoma. Faik Erdogan M; Gursoy A; Erdogan G; Kamel N Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922 [TBL] [Abstract][Full Text] [Related]
34. Treatment of "locally advanced" well-differentiated thyroid carcinomas. Falvo L; Catania A; Grilli P; Di Matteo FM; De Antoni E Ann Ital Chir; 2004; 75(1):17-21. PubMed ID: 15283382 [TBL] [Abstract][Full Text] [Related]
35. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study. Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265 [TBL] [Abstract][Full Text] [Related]